Clinical trial

Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor…

NCT00005851 · Fred Hutchinson Cancer Center, Other · Completed

Key facts

NCT number NCT00005851
Title Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer
Official title Phase I/II Study of HLA-Matched Non-Myeloablative Peripheral Blood Mobilized Hematopoietic Progenitor Cell Transplantation as Treatment for Patients With Metastatic Renal Cell Carcinoma. A Multi-Center Trial.
Lead sponsor Fred Hutchinson Cancer Center, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
Intervention type Biological, Drug, Other, Procedure, Radiation
Interventions fludarabine phosphate, total-body irradiation, nonmyeloablative allogeneic hematopoietic stem cell transplantation, cyclosporine, mycophenolate mofetil, peripheral blood stem cell transplantation, therapeutic allogeneic lymphocytes, laboratory biomarker analysis
Enrollment 11
Start date Feb 1, 2000
Primary completion Jul 1, 2004
Completion Sep 27, 2018
First posted Jan 27, 2003
Last update posted Jul 24, 2019
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies